Immunological and Antitumor Effects of IL-23 as a Cancer Vaccine Adjuvant

The promising, but modest, clinical results of many human cancer vaccines indicate a need for vaccine adjuvants that can increase both the quantity and the quality of vaccine-induced, tumor-specific T cells. In this study we tested the immunological and antitumor effects of the proinflammatory cytok...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Overwijk, Willem W., de Visser, Karin E., Tirion, Felicia H., de Jong, Laurina A., Pols, Thijs W. H., Velden, Yme U. van der, Boorn, Jasper G. van den, Keller, Anna M., Buurman, Wim A., Theoret, Marc R., Blom, Bianca, Restifo, Nicholas P., Kruisbeek, Ada M., Kastelein, Robert A., Haanen, John B. A. G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2242845/
https://ncbi.nlm.nih.gov/pubmed/16621986
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados